PhillyPharma Archive: February, 2012

BIO's Greenwood wants a 'Manhattan Project' for Alzheimer's

Comment icon 0 Comments
The 18th annual Wharton Health Care Business Conference last week at the Hyatt at the Bellevue on South Broad had the usual high concentration... Read more

Johnson & Johnson CEO Bill Weldon to be replaced by Alex Gorsky

Comment icon 0 Comments
Johnson & Johnson chief executive officer Bill Weldon, 63, will retire in April, after a string of recalls that have embarrassed the health-care... Read more

Pfizer working to sell or spin off infant-nutrition, animal-health units

Comment icon 0 Comments
Pfizer, which is based in Manhattan but has units in the Philadelphia area, said last year it would explore options for its animal health unit... Read more

Drugs prices too high or too low?

Comment icon 0 Comments
Health and Human Service Secretary Kathleen Sebelius chaired a panel discussion Thursday afternoon at the African American Museum and the focus... Read more

Synthes reports profit jump of 6.5 percent in 2011

Comment icon 0 Comments
Synthes, Inc., the medical device manufacturer with operations in Chester County, reported that it increased profit by 6.5 percent in 2011... Read more

Drugmaker Teva says it's prepared in case of attack on Israel

Comment icon 0 Comments
Without actually saying "Iran," Teva Pharmaceuticals chief executive officer Shlomo Yanai said Wednesday that the Israel-based company was... Read more

Teva reports bump from Cephalon, but struggles in U.S. generic market

Comment icon 0 Comments
Teva Pharmaceuticals reported increases in non-GAAP profit and revenue for all of 2011 and the fourth quarter, but the results were skewed... Read more

GSK trying for culture shift ... and more profit

Comment icon 0 Comments
Coming out of 2011, GlaxoSmithKline hopes that it turned a corner, with leaders saying they hope several years of changes will result in higher... Read more